Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:caplaa01

Total Results:

1353


Ethics of Artificial Intelligence in Medicine and Ophthalmology

Abdullah, Yasser Ibraheem; Schuman, Joel S; Shabsigh, Ridwan; Caplan, Arthur; Al-Aswad, Lama A
BACKGROUND:This review explores the bioethical implementation of artificial intelligence (AI) in medicine and in ophthalmology. AI, which was first introduced in the 1950s, is defined as "the machine simulation of human mental reasoning, decision making, and behavior". The increased power of computing, expansion of storage capacity, and compilation of medical big data helped the AI implementation surge in medical practice and research. Ophthalmology is a leading medical specialty in applying AI in screening, diagnosis, and treatment. The first Food and Drug Administration approved autonomous diagnostic system served to diagnose and classify diabetic retinopathy. Other ophthalmic conditions such as age-related macular degeneration, glaucoma, retinopathy of prematurity, and congenital cataract, among others, implemented AI too. PURPOSE/OBJECTIVE:To review the contemporary literature of the bioethical issues of AI in medicine and ophthalmology, classify ethical issues in medical AI, and suggest possible standardizations of ethical frameworks for AI implementation. METHODS:Keywords were searched on Google Scholar and PubMed between October 2019 and April 2020. The results were reviewed, cross-referenced, and summarized. A total of 284 references including articles, books, book chapters, and regulatory reports and statements were reviewed, and those that were relevant were cited in the paper. RESULTS:Most sources that studied the use of AI in medicine explored the ethical aspects. Bioethical challenges of AI implementation in medicine were categorized into 6 main categories. These include machine training ethics, machine accuracy ethics, patient-related ethics, physician-related ethics, shared ethics, and roles of regulators. CONCLUSIONS:There are multiple stakeholders in the ethical issues surrounding AI in medicine and ophthalmology. Attention to the various aspects of ethics related to AI is important especially with the expanding use of AI. Solutions of ethical problems are envisioned to be multifactorial.
PMID: 34383720
ISSN: 2162-0989
CID: 5010852

COVID vaccine efficacy against the B.1.351 ("South African") variant-The urgent need to lay the groundwork for possible future challenge studies

Eyal, Nir; Caplan, Arthur; Plotkin, Stanley
PMID: 33905309
ISSN: 2164-554x
CID: 4868102

Gene therapy companies have an ethical obligation to develop expanded access policies

Kearns, Lisa; Chapman, Carolyn Riley; Moch, Kenneth I; Caplan, Arthur L; Watson, Tom; McFadyen, Andrew; Furlong, Pat; Bateman-House, Alison
PMID: 33714373
ISSN: 1525-0024
CID: 4821312

A Letter to President Biden and Secretary Designate of HHS Xavier Becerra: Remove Barriers to Federal Funding of Human Embryo and Fetal Tissue Research

Santoro, Nanette; Caplan, Arthur; Strauss, Jerome; Winn, Virginia D
Human fetal tissue (HFT) has been used in biomedical research for nearly a century and has led to extraordinarily valuable discoveries that have benefitted humankind. Politicization of the use of HFT over recent years has led to the creation of numerous obstacles to scientific progress in this field. In July 2019, the imposition of redundant ethics policies was supplemented with the creation of the Human Fetal Tissue Ethics Advisory Board, which withheld funding of 13 out of 14 NIH grants that were favorably peer reviewed in the Summer of 2020. We believe that these new sets of restrictions are harmful to the goals of scientific progress and call upon the new administration of our government to allow peer review, not politics, to determine scientific merit and to reinstitute the previously existing ethics policies that were more than adequate to assure the appropriateness of human fetal tissue research.
PMCID:7909373
PMID: 33638133
ISSN: 1933-7205
CID: 4812592

Trial participants' rights after authorisation of COVID-19 vaccines [Letter]

Dal-Ré, Rafael; Orenstein, Walter; Caplan, Arthur L
PMCID:7816575
PMID: 33476582
ISSN: 2213-2619
CID: 4798762

Executive summary: It's wrong not to test: The case for universal, frequent rapid COVID-19 testing

Johnson-León, Maureen; Caplan, Arthur L; Kenny, Louise; Buchan, Iain; Fesi, Leah; Olhava, Phoebe; Nsobila Alugnoa, Desmond; Aspinall, Mara G; Costanza, Emily; Desharnais, Brianna; Price, Corinne; Frankle, Jon; Binding, Jonas; Working Group, Rapid Tests; Ramirez, Cherie Lynn
PMCID:7894218
PMID: 33644720
ISSN: 2589-5370
CID: 4836402

COVID-19 vaccine research and the trouble with clinical equipoise [Letter]

Friesen, Phoebe; Caplan, Arthur L; Miller, Jennifer E
PMID: 33539728
ISSN: 1474-547x
CID: 5081632

Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine [Editorial]

Dal-Ré, Rafael; Caplan, Arthur L; Gluud, Christian; Porcher, Raphaël
PMID: 33216636
ISSN: 1539-3704
CID: 4681422

How Should We Regard Information Gathered in Nazi Experiments?

Caplan, Arthur L
Immorally acquired information from Nazi experimentation or other sources infects the body of scientific and biomedical knowledge. Responding to this reality ethically means insisting on good teaching about the horrific history of such information's sources and careful deliberation about how it is referenced and described.
PMID: 33554849
ISSN: 2376-6980
CID: 4799102

Should the Regulation of Research Misconduct Be Integrated with the Ethics Framework Promulgated in The Belmont Report?

Redman, Barbara K; Caplan, Arthur L
The federal research misconduct regulations finalized in 2005 did not incorporate important principles regarding human subjects protections articulated in The Belmont Report, yet research misconduct can involve harms to research subjects and to subsequent patients whose treatments are based on false research findings. Consistency with the Belmont principles would require assuring regular monitoring to detect research misconduct, tracing effects of research misconduct on trial participants and informing them of these effects, and assuring timely correction of published reports of research findings if research misconduct related to the study was subsequently discovered. Research misconduct has historically been viewed as a matter for the scientific community to manage; it is actually a threat to the welfare of human subjects and ethically ought to be treated as such.
PMID: 33463076
ISSN: 2578-2363
CID: 4771572